Clinical trials
Cardiology clinical trials
Below are recruiting cardiology clinical trials, each written for real people, not researchers. We’re tracking 106 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06465459Recruiting
Testing the LAMBRE device for left atrial appendage closure
This study is testing a device called LAMBRE that is used to close a small pocket in the heart (the left atrial appendage). The goal is to see how well it works in everyday medical practice for people who need this closure procedure.
PessacAges 18 years+ - NCT06495177Recruiting
Survey on heart disease and diabetes prevention
This survey studies how well heart disease, diabetes, and kidney disease are being prevented and managed across Europe. If you've had a heart event or are taking medicines for high blood pressure, cholesterol, or diabetes, this study wants to learn from your experience.
IstanbulAges 18 years+ - NCT06548269Recruiting
Assessing stroke recovery in patients with atrial fibrillation
This study watches how people recover from a recent stroke caused by a heart rhythm problem called atrial fibrillation (or AFib). It aims to find better ways to predict recovery and guide future care.
Jinan, ShandongAges 18 years+ - NCT07296744Recruiting
Study of a heart pump for high-risk angioplasty
This trial tests a new device called the Supira system to support the heart during a high-risk procedure to open blocked arteries. It is for people who are stable enough to wait for the procedure (not in emergency or shock).
Loma Linda, CaliforniaAges 18–90 - NCT06655480RecruitingPhase 2
Triple drug therapy for advanced heart failure with preserved ejection fraction
This trial tests a combination of three heart failure drugs (ARNI, SGLT2i, MRA) to see if they improve symptoms and outcomes in people with a type of heart failure where the heart pumps normally but doesn't relax properly (HFpEF).
MoscowAges 40–80 - NCT06694181Recruiting
Safe and explainable AI for heart, sepsis, and breast cancer patients
This trial uses artificial intelligence (AI) to create prediction models for three groups: cardiology patients, sepsis patients, and breast cancer patients. It aims to make these models safe and easy to understand for doctors.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06736665Recruiting
Comparing two ways to treat hardened calcium in heart arteries
This trial compares two techniques (orbital atherectomy and intravascular lithotripsy) to break up tough calcium deposits in the heart's arteries that can block blood flow. If you have a calcified nodule and are having a non-emergency procedure to open a blocked artery, this study may help guide which method works best.
Alicante, AlicanteAges 18 years+ - NCT06753591Recruiting
Premature heart attack registry in Serbia
This trial is creating a registry of young adults (45 and under) who have had a heart attack. It will collect information to help doctors better understand and treat early heart attacks.
BelgradeAges 18–45 - NCT06769269Recruiting
Hypertension registry study in Morocco
This study is creating a registry of people with high blood pressure in Morocco. It aims to understand different types of hypertension, related health problems, and how to personalize treatment.
Meknes, MoroccoAges 18 years+ - NCT06798714RecruitingPhase 4
Colchicine to prevent irregular heartbeat after heart surgery
This trial tests whether the drug colchicine can reduce the chance of developing atrial fibrillation (an irregular heart rhythm) after open-heart surgery. If it works, it could help you recover more smoothly.
TomskAges 18 years+ - NCT06818435Recruiting
Registry study of the Myval heart valve for severe aortic stenosis
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
CarnaxideAges 18 years+ - NCT06826872RecruitingPhase 2
Testing SPC1001 for essential hypertension
This trial tests an oral medication called SPC1001 to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure not caused by another condition). It may help if you have mild to moderate high blood pressure.
SeoulAges 19–75 - NCT06833138Recruiting
Pacing vs medication for heart rate control in AF with heart failure
This trial tests whether a procedure that regulates your heart rhythm (pacing) works better than medication for people who have permanent atrial fibrillation, heart failure with a normal pumping strength, and were hospitalized for heart failure in the past year.
AalstAges 18 years+ - NCT06839755Recruiting
Stress echo's positive value in heart health
This study looks at how well a stress echocardiogram (heart ultrasound during exercise or medication) predicts future health in people who have some sign of reduced blood flow to the heart. The goal is to confirm that a positive stress echo is a good sign for guiding next steps.
Athens, AtticaAges 18–100 - NCT06844032Recruiting
Predictors of poor outcome in heart failure with normal pumping
This study looks at people with heart failure who still have a normal pumping ability (HFpEF). Researchers want to find what factors predict a worse outcome, so they can better understand and treat this condition.
MoscowAges 40 years+ - NCT06878729Recruiting
Comparing two ways to open a blocked heart artery
This trial tests two procedures—antegrade dissection/re-entry and the retrograde method—to treat a completely blocked artery. It compares which technique works better for patients with complex blockages.
Warsaw, WarsawAges 18 years+ - NCT06898307Recruiting
Genetic test study for inherited heart rhythm conditions
This study uses genetic testing to better diagnose, predict, and manage inherited heart rhythm diseases. It is designed for patients at the University of Ferrara's Cardiogenetic Center who have a confirmed genetic heart condition.
FerraraAges Any age - NCT07008391Recruiting
High-sensitivity troponin test in ambulance care
This trial tests whether using a high-sensitivity troponin I test in the ambulance, along with standard care, can help emergency medical services better identify heart attacks. This might lead to faster treatment for patients with chest pain or suspected heart attack.
Stockholm, ÅrstaAges 18 years+ - NCT07025590Recruiting
Exercise to help lower antidepressants for heart patients
This trial tests whether adding a structured exercise program can help people with both depression/anxiety and heart disease slowly reduce their antidepressant medication. It may offer a way to lower medication use while improving heart and mental health.
Guangzhou, GuangdongAges 18–70 - NCT07039149Recruiting
Dual antiplatelet therapy for acute coronary syndrome
This trial tests giving two blood-thinning medicines early to people who have had a heart attack or unstable chest pain. Researchers want to see if this approach reduces future heart problems.
AmmanAges 18 years+ - NCT07112391Recruiting
Pressure volume loop study for valve disease
This trial uses a special heart test called pressure volume loop assessment to better understand how well your heart pumps when you have severe valve disease. It aims to find patterns that may help doctors treat you more effectively. You may join if you have certain types of severe heart valve problems.
Nantes, Loire AtlantiqueAges 18 years+ - NCT07131605Recruiting
How weight-loss surgery affects heart health and inflammation
This study looks at how weight-loss surgery affects heart health by checking markers of inflammation in the blood and how blood vessels work. It may help understand why surgery lowers heart risk for people with obesity.
Cotignola, RavennaAges 18 years+ - NCT07144189Recruiting
AI helps diagnose low-gradient aortic stenosis
This trial is testing whether an artificial intelligence (AI) program can better identify low-gradient aortic stenosis, a type of heart valve narrowing, by looking at your echocardiogram (heart ultrasound). It aims to help doctors diagnose this condition more accurately without any extra procedures.
Warsaw, Masovian VoivodeshipAges 18 years+ - NCT07149714Recruiting
Heart pump support for high-risk angioplasty
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
MoscowAges 18 years+
Hear when a new Cardiology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiology?
- Yes. Clin2 currently lists 106 recruiting cardiology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.